Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

BACKGROUND: Osteosarcoma is the most common malignant primary bone tumour in young adult treated by neo adjuvant chemotherapy, surgical tumor removal and adjuvant multidrug chemotherapy. For correction of soft tissue defect consecutive to surgery and/or tumor treatment, autologous fat graft has been...

Full description

Bibliographic Details
Main Authors: Pierre Perrot, Julie Rousseau, Anne-Laure Bouffaut, Françoise Rédini, Elisabeth Cassagnau, Frédéric Deschaseaux, Marie-Françoise Heymann, Dominique Heymann, Franck Duteille, Valérie Trichet, François Gouin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2882323?pdf=render

Internet

http://europepmc.org/articles/PMC2882323?pdf=render

Similar Items